Genital Herpes Simplex Type 2
7 clinical trials · Condition
◉ Watch Genital Herpes Simplex Type 2
| Record | Firm | Date |
|---|---|---|
| A Clinical Trial in Healthy Volunteers and Volunteers With Recurrent Genital Herpes to Study the Safety, Tolerability, and Immune Responses After Vaccination With an Investigational Vaccine Designed to Prevent Genital Herpes Lesions (NCT05432583) | BioNTech SE | 2022-12-08 |
| Long-term Follow-up of GEN-003-002 Subjects for Efficacy and Immunogenicity (NCT02910284) | Genocea Biosciences, Inc. | 2016-09-16 |
| Evaluating New Formulation of Therapeutic HSV-2 Vaccine (NCT02515175) | Genocea Biosciences, Inc. | 2015-11-01 |
| Rollover Trial for Placebo Subjects Previously Enrolled Into GEN-003-002 Study (NCT02300142) | Genocea Biosciences, Inc. | 2015-01-01 |
| Dose Ranging Safety and Efficacy of Therapeutic HSV-2 Vaccine (NCT02114060) | Genocea Biosciences, Inc. | 2014-07-01 |
| Safety and Efficacy Trial of DNA Vaccines to Treat Genital Herpes in Adults (NCT02030301) | Vical | 2013-12-01 |
| Safety and Immunogenicity Study of Therapeutic HSV-2 Vaccine (NCT01667341) | Genocea Biosciences, Inc. | 2012-07-01 |
Track Genital Herpes Simplex Type 2 automatically
Every clearance here is in the API, with alerts when new ones post.